Colonic epithelial cell diversity in health and inflammatory bowel disease

The colonic epithelium facilitates host–microorganism interactions to control mucosal immunity, coordinate nutrient recycling and form a mucus barrier. Breakdown of the epithelial barrier underpins inflammatory bowel disease (IBD). However, the specific contributions of each epithelial-cell subtype...

Full description

Saved in:
Bibliographic Details
Published inNature (London) Vol. 567; no. 7746; pp. 49 - 55
Main Authors Parikh, Kaushal, Antanaviciute, Agne, Fawkner-Corbett, David, Jagielowicz, Marta, Aulicino, Anna, Lagerholm, Christoffer, Davis, Simon, Kinchen, James, Chen, Hannah H., Alham, Nasullah Khalid, Ashley, Neil, Johnson, Errin, Hublitz, Philip, Bao, Leyuan, Lukomska, Joanna, Andev, Rajinder Singh, Björklund, Elisabet, Kessler, Benedikt M., Fischer, Roman, Goldin, Robert, Koohy, Hashem, Simmons, Alison
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.03.2019
Nature Publishing Group
Subjects
13
14
38
82
Online AccessGet full text
ISSN0028-0836
1476-4687
1476-4687
DOI10.1038/s41586-019-0992-y

Cover

More Information
Summary:The colonic epithelium facilitates host–microorganism interactions to control mucosal immunity, coordinate nutrient recycling and form a mucus barrier. Breakdown of the epithelial barrier underpins inflammatory bowel disease (IBD). However, the specific contributions of each epithelial-cell subtype to this process are unknown. Here we profile single colonic epithelial cells from patients with IBD and unaffected controls. We identify previously unknown cellular subtypes, including gradients of progenitor cells, colonocytes and goblet cells within intestinal crypts. At the top of the crypts, we find a previously unknown absorptive cell, expressing the proton channel OTOP2 and the satiety peptide uroguanylin, that senses pH and is dysregulated in inflammation and cancer. In IBD, we observe a positional remodelling of goblet cells that coincides with downregulation of WFDC2—an antiprotease molecule that we find to be expressed by goblet cells and that inhibits bacterial growth. In vivo, WFDC2 preserves the integrity of tight junctions between epithelial cells and prevents invasion by commensal bacteria and mucosal inflammation. We delineate markers and transcriptional states, identify a colonic epithelial cell and uncover fundamental determinants of barrier breakdown in IBD. Profiling of single epithelial cells in healthy and inflamed colons identifies specialized cellular subpopulations, including a type of goblet cell that secretes the antibacterial protein WFDC2, which preserves the integrity of the epithelial barrier layer.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ISSN:0028-0836
1476-4687
1476-4687
DOI:10.1038/s41586-019-0992-y